Colorectal cancer is one common digestive malignancy, and the most common approach of blood metastasis of colorectal cancer is through the portal vein system to the liver. Early detection and treatment of liver metastasis is the key to improving the prognosis of the patients. Radiomics and radiogenomics use non-invasive methods to evaluate the biological properties of tumors by deeply mining the texture features of images and quantifying the heterogeneity of metastatic tumors. Radiomics and radiogenomics have been applied widely in the detection, treatment, and prognostic evaluation of colorectal cancer liver metastases. Based on the imaging features of the liver, this paper reviews the current application of radiomics and radiogenomics in the diagnosis, treatment, monitor of disease progression, and prognosis of patients with colorectal cancer liver metastases.
基金：
Hebei Natural Science Foundation Project [H20212017]; Project of Hebei Provincial Department of finance [361007]; Medical Discipline Cultivation Project of Hebei University [2020b05]
第一作者机构：[1]Hebei Univ, Affiliated Hosp, CT MRI Room, Baoding, Peoples R China
通讯作者：
推荐引用方式(GB/T 7714)：
Wang Yun,Ma Lu-Yao,Yin Xiao-Ping,et al.Radiomics and Radiogenomics in Evaluation of Colorectal Cancer Liver Metastasis[J].FRONTIERS IN ONCOLOGY.2022,11:doi:10.3389/fonc.2021.689509.
APA：
Wang, Yun,Ma, Lu-Yao,Yin, Xiao-Ping&Gao, Bu-Lang.(2022).Radiomics and Radiogenomics in Evaluation of Colorectal Cancer Liver Metastasis.FRONTIERS IN ONCOLOGY,11,
MLA：
Wang, Yun,et al."Radiomics and Radiogenomics in Evaluation of Colorectal Cancer Liver Metastasis".FRONTIERS IN ONCOLOGY 11.(2022)
